Company News
- 26.05.08
Study Data published
SIRS-Lab published a new Application Note of its Sepsis test VYOO. Objective of the study was to compare VYOO with current standard methods for pathogen detection in sepsis. The results show the competitive sensitivity and specificity of the molecular sepsis solution. Download the...
read more » - 05.05.08
SIRS-Lab at Austria’s Top Diagnostic Events
After the successful ECCMID in Barcelona, the VYOO sepsis test Roadshow continues its successful journey throughout Europe and stops for two outstanding meetings in Graz, Austria:
May 13-17, Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Booth 6
May 22-24, International Symposium on Molecular Diagnostics (ISMD), Booth 5
These symposia assemble the top innovators in molecular diagnostics. Within the excellent scientific program, we especially recommend...
read more » - 04.04.08
Where experts meet – SIRS-Lab at the ECCMID Barcelona
Barcelona; The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) from April 19 – 22 will be the next station in SIRS-Lab’s successful VYOO sepsis test Roadshow. Come to our booth number 445 and learn more about VYOO’s clinical utility and the impact on your detection processes. Attend the individual short lectures by our microbiology team and profit from special congress offers.
read more » - 17.01.08
SIRS-Lab at Shock Conference 2008 Cologne
Together with international top Scientists, SIRS-Lab will hold a workshop on the significance of gene-activity based sepsis diagnostics. The workshop will take place Sunday June 29th. Read more about registration and program...
read more » - 10.12.07
Sepsis Diagnostics Review
SIRS-Lab places an article in the current Laborwelt issue on Clinical Diagnostics. The issue deals with current standard methods and new trends in pathogen detection in sepsis. In the article called "Fast and sensitive sepsis pathogen detection" clincial validity of SIRS-Lab's PCR detection assay VYOO is explained. The presented study data shows VYOO's application and potential in sepsis pathogen detection.
read more » - 13.11.07
SIRS-Lab sponsors Research Conference
SIRS-Lab acted as sponsor of the „Jenaer Denkanstösse“ on November 10th held by the German National Academic Foundation, Germany’s largest and most prestigious organisation sponsoring the academically gifted. Being a reliable partner for young researchers is an important point in SIRS-Lab’s activities.
read more » - 08.10.07
Roadshow in Berlin
The SIRS-Lab team is recently attending the ESICM in Berlin. Meet our experts there. Moreover SIRS-Lab will be present at Biotechnica's postersession in Hannover on Thuesday the 9th.
read more » - 04.09.07
SIRS-Lab at Major Sepsis Congress
Currently, SIRS-Lab is presenting its new product VYOO™ at the "Third International Congress Sepsis and Multiorgan Dysfunction" in Weimar, Germany. First studies about VYOO™ will be presented there. Meet the SIRS-Lab team at booth 17 and in the exclusive VYOO™ lounge.
read more » - 21.03.07
Expert service for gene expression studies - Quality internationally accepted
After only five years, SIRS-Lab has successfully established itself as the commercial provider of gene expression studies. In this fast-paced field, SIRS-Lab counts on the know how of an interdisciplinary team which possesses more than one hundred man-years of expertises in biochip technology.
read more » - 16.11.06
SIRS-Lab achieves key milestone in development of sepsis
SIRS-Lab GmbH announced today the successful identification of a set of gene expression biomarkers that closely correlate with the cause of multiorgan failure in sepsis.
read more » - 06.02.06
SIRS-Lab´s quality management was confirmed
SIRS-Lab GmbH works conform to internationally approved quality standards. This was concluded by the auditor from the TÜV Thüringen during the annual surveillance audit. “We are very pleased that the audit confirmed full compliance to the DIN EN ISO 9001:2000 regulations,” says Markus Bläss, Head of Quality Assurance.
read more »
- 30.05.08
Excellent workshop program published
In the course of the International Shock Congress (Cologne June 28 – July 2), SIRS-Lab will host the cutting edge workshop “Microarray – Tool or Toy”. Register now for the congress and join the workshop with lectures from: Michael Bauer, Peter Biberthaler, Friedemann Horn, Matthias Kohl, Chris Thiemermann, and Yoram Vodovotz. Read more about the workshop program, registration (discount prior to April 15), and the congress here…
read more » - 05.03.08
Roadshow in Frankfurt and Brussels
SIRS-Lab continues its successful Roadshow with two outstanding expert meetings in microbiology and intensive care medicine. In March, we present our molecular diagnostic suite at the VAAM Frankfurt/Main, Germany and the ISICEM Brussels, Belgium.
read more » - 21.01.08
Donation for Tolerance
SIRS-Lab donated its budget for Christmas Cards to the “Committee for civil courage and against intolerance” in Jena. The regional association “Kokont” stands for the support of “human rights” and connects different initiatives of the city. SIRS-Lab wants to promote this important work and encourage the civil engagement.
read more » - 15.11.07
SIRS-Lab wins Innovation Award
The R&D collaboration with the University Hospital Jena and the University of Applied Science Jena is valued with the Thuringian Innovation Award 2007. The awarded core innovation is LOOXSTER's ability to concentrate fungal DNA. With VYOO, sepsis specific bacterial and fungal species can then be detected. The Jury, consisting of high representatives from science and business organizations...
read more » - 23.10.07
Discover regulatory RNA with extended Gene Expression Service
miRNA analysis now available: SIRS-Lab’s gene expression profile is now extended with the accurate measurement of regulatory RNA. The new Illumina MicroRNA Expression Profiling Panels enable the analysis of all currently known miRNAs, an important class of regulatory RNA.
read more » - 28.09.07
Roadshow in Göttingen and Edinburgh
The VYOO™ Roadshow continues. SIRS-Lab will attend the DGHM in Göttingen, Germany from Sunday Oct 1st till Thursday Oct 4th. SIRS-Lab’s team is looking forward to meeting you there. At the same time, Oct 1st, Dr. Britta Wlotzka visits the Edinburgh University to talk at the seminar “Multiparameter Detection and Diagnostics". For more information on the meetings, please...
read more » - 19.09.07
SIRS-Lab founds Hugo Schottmüller Prize for Sepsis Research
The prize is awarded by the German Sepsis Society for exceptional achievements in Sepsis research. At the 3rd International Congress Sepsis and Multiorgan Dysfunction in Weimar, Dr. S. Wirtz from the University Hospital Mainz, Germany, received this year’s award which is endowed by SIRS-Lab with 3000 Euro.
read more » - 11.09.07
Successful VYOO™ Presentation
The SIRS-Lab team is back from the „Third International Congress Sepsis and Multiorgan Dysfunction” in Weimar, Germany. At this Event, VYOO™ was launched successfully. Many interested experts joined the discussion about new ways in sepsis care.
read more » - 05.09.07
VYOO™ Market Launch
SIRS-Lab launches VYOO™, a novel DNA-based test for the detection of sepsis pathogens. Within 6 hours, information of high therapeutic value are delivered. The system is currently presented at the "Third International Congress Sepsis and Multiorgan Dysfunction" in Weimar, Germany.
read more » - 06.06.07
Step by Step - SIRS-Lab donates 1000 € for Sepsis Research
A 24 hours walk and every kilometre counts: Dr. Peter Bauer, a committed scientist in Sepsis research, took the challenge of a 100 km trip to raise donations for Sepsis research. SIRS-Lab was impressed by this idea and decided to assign 10 Euro for each kilometre Dr. Bauer brings under his feet. In the end, he managed to go the whole distance and SIRS-Lab donated 1000 Euro.
read more » - 14.12.06
SIRS-Lab successfully raises EURO 10M new equity capital to introduce its first
SIRS-Lab, the innovation leader in molecular diagnostics for life threatening infections announced today that it has successfully raised EURO 10 million new equity capital led by Affentranger Associates alongside with bm-t Beteiligungsmanagement Thüringen and Swiss institutional investors.
read more »